首页> 外文期刊>Injury >Comparison of the effects of dexketoprofen trometamol, meloxicam and diclofenac sodium on fibular fracture healing, kidney and liver: An experimental rat model
【24h】

Comparison of the effects of dexketoprofen trometamol, meloxicam and diclofenac sodium on fibular fracture healing, kidney and liver: An experimental rat model

机译:右酮洛芬,丁苯丙胺,美洛昔康和双氯芬酸钠对腓骨骨折愈合,肾脏和肝脏的影响的比较:实验性大鼠模型

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives Nonsteroidal anti-inflammatory drugs (NSAIDs) are particularly used in patients with bone fractures, but there are limited studies on whether one NSAID is superior to another. In this study, we used histopathological and biochemical parameters to determine whether there are differences between the effects of the administration of clinical doses of dexketoprofen trometamol (DEXT), meloxicam (MEL) and diclofenac sodium (DIC) on the healing of closed fibular fractures and the toxicity of both the liver and kidney. Methods Twenty-eight male Sprague-Dawley rats were randomly divided into four groups of seven each. Closed diaphyseal fractures were formed in the left fibulas of all of the rats. The NSAIDs dexketoprofen trometamol (DEXT) (Arveles ?), meloxicam (MEL) (Melox?) and diclofenac sodium (DIC) (Voltaren?) were intramuscularly administered to Groups I, II, and III, respectively, for a period of 10 days after the fibular fractures were performed. No pharmacological agents were administered to Group IV (Control group). Blood samples were collected from all of the rats after the fractures were performed, and the rats were sacrificed on day 28. The histopathological findings were compared, and the blood samples were evaluated to determine any differences between the levels of superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA). Results Our results suggest that DEXT and MEL impair the healing of bone fractures and that DIC does not histopathologically affect the healing process of bone fractures. We also found that DEXT, MEL, and DIC impaired the renal histopathology compared with the control group. However, the liver histopathological analysis showed that DEXT and MEL caused a higher degree of parenchymal necrosis compared with DIC. Conclusion Based on our results, DIC can be considered a relatively safe medication in patients with fractures.
机译:目的非甾体类抗炎药(NSAIDs)特别用于骨折患者,但是关于一种NSAID是否优于另一种的研究还很有限。在这项研究中,我们使用组织病理学和生化参数来确定临床剂量右旋苯丙酸苯丁胺醇(DEXT),美洛昔康(MEL)和双氯芬酸钠(DIC)对闭合性腓骨骨折愈合的影响是否存在差异。肝脏和肾脏的毒性。方法28只雄性Sprague-Dawley大鼠随机分为四组,每组七只。在所有大鼠的左腓骨中均形成了闭合性骨干骨折。将非甾体抗炎药右旋苯丙酸苯丙胺(DEXT)(Arveles?),美洛昔康(MEL)(Melox?)和双氯芬酸钠(DIC)(Voltaren?)分别肌肉注射至I,II和III组,持续10天。进行腓骨骨折后。未将药物药施用至第IV组(对照组)。进行骨折后,从所有大鼠中收集血样,并在第28天处死大鼠。比较组织病理学发现,并评估血样以确定超氧化物歧化酶(SOD)水平之间的任何差异,过氧化氢酶(CAT)和丙二醛(MDA)。结果我们的结果表明DEXT和MEL损害了骨折的愈合,而DIC并未在组织病理学上影响骨折的愈合过程。我们还发现,与对照组相比,DEXT,MEL和DIC损害了肾脏的组织病理学。然而,肝脏组织病理学分析显示,与DIC相比,DEXT和MEL引起更高程度的实质性坏死。结论根据我们的结果,DIC可被认为是骨折患者相对安全的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号